# Atara Biotherapeutics funding: rounds and investors

> Atara Biotherapeutics has raised $69M across 4 rounds since 2013. Investors include Kleiner Perkins Caufield & Byers, Kleiner Perkins and DAG Ventures.

Source: https://millionrounds.com/company/atara-biotherapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Funded startup](https://millionrounds.com/companies)

# Who invested in *Atara Biotherapeutics*

4 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 6 months ago

Funding summary Updated 26 Oct 2026

**$69M** raised across 4 rounds since 2013, from 4 sources

**$39M** Series B **$14M** Series B **$16M** Round **$550K** Round

- **Latest round:** Round, $550K May 2026
- **Biggest round:** $39M Series B · Dec 2013
- **Investors:** 9

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015 2017 2019 2021 2023 2025

**$39M** Series B

**$14M** Series B

**$16M** Round

**$550K** Round

- **First round:** Series B, $39M
- **Biggest round:** $39M
- **Usual gap between rounds:** 11.3 years

## The rounds

- **May 2026** Round **$550K** *2 returning* [Kleiner Perkins](https://millionrounds.com/fund/kleiner-perkins) [Redmile Group](https://millionrounds.com/fund/redmile-group) Source recorded
- **May 2025** Round **$16M** *2 new* [Kleiner Perkins](https://millionrounds.com/fund/kleiner-perkins) [Redmile Group](https://millionrounds.com/fund/redmile-group) Source recorded
- **Jan 2014** Series B **$14M** *1 new* *6 returning* [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) [DAG Ventures](https://millionrounds.com/fund/dag-ventures) [Domain Associates](https://millionrounds.com/fund/domain-associates) [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) [Celgene](https://millionrounds.com/fund/celgene) [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) [Amgen Ventures](https://millionrounds.com/fund/amgen-ventures) From a historical funding record
- **Dec 2013** Series B **$39M** *6 new* [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) [DAG Ventures](https://millionrounds.com/fund/dag-ventures) [Domain Associates](https://millionrounds.com/fund/domain-associates) [Celgene](https://millionrounds.com/fund/celgene) [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) [Amgen Ventures](https://millionrounds.com/fund/amgen-ventures) From a historical funding record

## Founders and team

From Atara Biotherapeutics's own website: 8 on the team.

- **Jim Sesic** Senior Vice President, Regulatory Affairs
- **Kevin Sarney** Interim Chief Financial Officer
- **Brian Cherry** Director
- **Gregory A. Ciongoli** Chairman of the Board
- **James Huang** Director
- **Matthew Fust** Director, Audit Committee Chair
- **Nachi Subramanian** Director
- **William Heiden** Director, Compensation Chair

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series B** 2013 **Series B** 2014 **Round** 2025 **Round** 2026 [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) [Kleiner Perkins](https://millionrounds.com/fund/kleiner-perkins) [DAG Ventures](https://millionrounds.com/fund/dag-ventures) [Domain Associates](https://millionrounds.com/fund/domain-associates) [Redmile Group](https://millionrounds.com/fund/redmile-group) [Celgene](https://millionrounds.com/fund/celgene) [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) [Amgen Ventures](https://millionrounds.com/fund/amgen-ventures) [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria)

## Everyone who backed them

[Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) VC firm **2** rounds

[Kleiner Perkins](https://millionrounds.com/fund/kleiner-perkins) VC firm **2** rounds

[DAG Ventures](https://millionrounds.com/fund/dag-ventures) VC firm **2** rounds

[Domain Associates](https://millionrounds.com/fund/domain-associates) VC firm **2** rounds

[Redmile Group](https://millionrounds.com/fund/redmile-group) VC firm **2** rounds

[Celgene](https://millionrounds.com/fund/celgene) Growth equity **2** rounds

[EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) Private equity **2** rounds

[Amgen Ventures](https://millionrounds.com/fund/amgen-ventures) Growth equity **2** rounds

[Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=atara-biotherapeutics).

## Quick answers about Atara Biotherapeutics

### Who invested in Atara Biotherapeutics?

Atara Biotherapeutics's investors include Kleiner Perkins Caufield & Byers, Kleiner Perkins, DAG Ventures, Domain Associates and Redmile Group, and 4 more on record.

### How much has Atara Biotherapeutics raised?

Atara Biotherapeutics has raised $69M across 4 rounds since 2013.

### When did Atara Biotherapeutics last raise?

Atara Biotherapeutics's most recent round was an Undisclosed round of $550K in May 2026.

### What was Atara Biotherapeutics's biggest round?

Atara Biotherapeutics's largest round on record is $39M (Series B), in Dec 2013.

### Who backed Atara Biotherapeutics first?

Atara Biotherapeutics's first round on record, in Dec 2013, was backed by Kleiner Perkins Caufield & Byers, DAG Ventures and Domain Associates and 3 others.

### What stage is Atara Biotherapeutics at?

Atara Biotherapeutics's latest named round is an Undisclosed round, in May 2026.

### Where is Atara Biotherapeutics based?

Atara Biotherapeutics is based in the United States.

## Companies like Atara Biotherapeutics

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
